Cambridge Cancer Genomics

Cambridge Cancer Genomics YC 申请

Summer 2017Inactive

Cambridge Cancer Genomics 在 Summer 2017 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。

YC 批次
Summer 2017
行业
HealthcareDiagnostics
团队规模
25
状态
Inactive
已发布
2017

创始人

  • John Cassidy
    John CassidyFounder/CEO
  • Nirmesh Patel
    Nirmesh PatelFounder/Chief Scientific Officer
  • Evaline Tsai
    Evaline TsaiFounder/CPO

Cambridge Cancer Genomics 做什么

CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. ‍ We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. We are expanding our team in Cambridge, UK, offering a fantastic opportunity for dedicated individuals who are comfortable in a high-work high-reward environment, and who are enthusiastic for a dynamic and varied role. We are looking for people who fit well into our team and company culture, and who like to overcome challenges and drive the business forward. In exchange, we offer a competitive salary with performance related bonuses and stock options, alongside excellent career development opportunities in a fast-growing start-up with a chance to truly impact how cancer is treated. To apply, please send your CV to

Cambridge Cancer Genomics 的 YC 申请,重建版

Y Combinator 申请

Cambridge Cancer Genomics,Summer 2017 期。来自公开数据的真实申请问题解答。

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Cambridge Cancer Genomics

Describe what your company does in 50 characters or less.

Personalized cancer treatment planning software

What is your company going to make? Please describe your product and what it does or will do.

We build software that helps oncologists interpret clinical and genomic data to pick the right drug for each cancer patient. Our platform analyzes patient biomarkers and treatment responses to guide precision oncology decisions.

Where do you live now, and where would the company be based after YC?

We currently live and work in Cambridge, England, United Kingdom, and the company remains based there.

Explain your decision regarding location.

Cambridge has the scientific and clinical expertise in genomics and oncology we need. Being close to hospitals and research centers allows faster collaboration and product validation.

21 更多回答 在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。

常见问题解答

这是 Cambridge Cancer Genomics 的真实 YC 申请吗?

不是。Y Combinator 对提交的申请保密。这是重建版:使用 Cambridge Cancer Genomics 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 Cambridge Cancer Genomics 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。

Cambridge Cancer Genomics 是哪个 YC 批次的?

Cambridge Cancer Genomics 是 Y Combinator Summer 2017 批次的成员。

谁创立了 Cambridge Cancer Genomics?

Cambridge Cancer Genomics 由 John Cassidy, Nirmesh Patel, Evaline Tsai 创立。

Cambridge Cancer Genomics 做什么?

CCG.ai empowers clinicians to make personalised treatment strategies…

如何阅读完整的重建申请?

创建免费的 Round Funded 账户。YC Insights 中包含 Cambridge Cancer Genomics 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。

更多 YC 初创公司,例如 Cambridge Cancer Genomics